Pathogenesis of polycythaemia vera
- 30 March 1996
- journal article
- Published by Elsevier in The Lancet
- Vol. 347 (9005) , 844-845
- https://doi.org/10.1016/s0140-6736(96)91338-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Molecular analysis of the erythropoietin receptor system in patients with polycythaemia veraBritish Journal of Haematology, 1994
- Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromesBlood, 1994
- Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia veraBlood, 1994
- Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium [see comments]Blood, 1994
- Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.Proceedings of the National Academy of Sciences, 1993
- Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factorBlood, 1992
- The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains.Molecular and Cellular Biology, 1991
- Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicityNature, 1990
- Polycythemia Vera: Stem-Cell and Probable Clonal Origin of the DiseaseNew England Journal of Medicine, 1976
- Bone-Marrow Responses in Polycythemia VeraNew England Journal of Medicine, 1974